Expression of Immunomodulatory Checkpoint Molecules in Drug-Resistant Neuroblastoma: An Exploratory Study.

Skertich, Nicholas J; Chu, Fei; Tarhoni, Imad A M; Szajek, Stephen; Borgia, Jeffrey A; Madonna, Mary Beth

Skertich, Nicholas J; Chu, Fei; Tarhoni, Imad A M; Szajek, Stephen; Borgia, Jeffrey A; Madonna, Mary Beth.

Afiliación

Skertich NJ; Department of Surgery, Division of Pediatric Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Chu F; Department of Surgery, Division of Pediatric Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Tarhoni IAM; Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA.
Szajek S; Department of Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Borgia JA; Department of Surgery, Division of Pediatric Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Madonna MB; Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA.

Cancers (Basel) ; 14(3)2022 Jan 31.

Article en En | MEDLINE | ID: mdl-35159017

Palabras clave

checkpoint molecule inhibition; checkpoint protein molecules; doxorubicin; drug resistance; neuroblastoma; programmed death ligand 1

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google